Infant neuroblastoma is one of the most clinically paradoxical cancers in medicine. Diagnosed during the first year of life, ...
Messenger ribonucleic acid (mRNA)-based therapeutics and the potential of mRNA as a treatment for various conditions has been researched for decades. A key challenge remains finding a delivery system ...
A new review of preclinical evidence shows that precision-engineered nanocarriers, from platelet-hitchhiking cancer drugs to ...
The molecular transport system could also serve as a platform for releasing other drugs in the body precisely at the target site. It's an old dream in pharmacy: To deliver an active ingredient to the ...
Scientists at Xi’an Jiaotong-Liverpool University (XJTLU) and at Nanjing University have combined a widely used medical polymer with a natural blood protein to develop a new nanoparticle drug delivery ...
Scientists have made a key breakthrough in treating respiratory diseases by developing a new drug delivery system that transports genetic therapies directly to the lungs, opening promising ...
University of Oklahoma researchers have created a new drug delivery system that helps cancer cells take in much more of a treatment, improving its ability to kill tumors. The findings are published in ...
Nanoparticle-based drug delivery systems harness engineered particles, typically in the 1–100 nanometre range, to transport therapeutic agents with enhanced precision, stability and efficacy. Lipid ...
Scientists at Xi'an Jiaotong-Liverpool University (XJTLU) and Nanjing University in China have developed a new drug delivery system that could improve how treatments of cancers and other diseases are ...
Newswise — INDIANAPOLIS — New research co-led by Indiana University School of Medicine scientists presents a significant step toward more precise and effective cancer treatments by using a ...
The treatment of central nervous system (CNS) disorders remains hampered by the selective permeability of the blood–brain barrier (BBB), which restricts the entry of most pharmacological agents.
Can you describe first researching lipid nanoparticles as a delivery vehicle? I’ve been in this game for a long time, since the early 80s, in terms of drug delivery. Before that, I was doing more ...